Cargando…

Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study

OBJECTIVE: To investigate conceptual knowledge about mammographic screening among Norwegian women. DESIGN: We administered a cross-sectional, web-based survey. We used multiple-choice questions and a grading rubric published by a research group from Australia. SETTING: Our Norwegian-language survey...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuruda, Kaitlyn M, Veierød, Marit B, Houssami, Nehmat, Waade, Gunvor G, Mangerud, Gunhild, Hofvind, Solveig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671979/
https://www.ncbi.nlm.nih.gov/pubmed/34907059
http://dx.doi.org/10.1136/bmjopen-2021-052121
_version_ 1784615262931124224
author Tsuruda, Kaitlyn M
Veierød, Marit B
Houssami, Nehmat
Waade, Gunvor G
Mangerud, Gunhild
Hofvind, Solveig
author_facet Tsuruda, Kaitlyn M
Veierød, Marit B
Houssami, Nehmat
Waade, Gunvor G
Mangerud, Gunhild
Hofvind, Solveig
author_sort Tsuruda, Kaitlyn M
collection PubMed
description OBJECTIVE: To investigate conceptual knowledge about mammographic screening among Norwegian women. DESIGN: We administered a cross-sectional, web-based survey. We used multiple-choice questions and a grading rubric published by a research group from Australia. SETTING: Our Norwegian-language survey was open from April to June 2020 and targeted women aged 45–74 years. PARTICIPANTS: 2033 women completed our questionnaire. We excluded 13 women outside the target age range and 128 women with incomplete data. Responses from 1892 women were included in the final study sample. PRIMARY AND SECONDARY OUTCOME MEASURES: The questionnaire focused on women’s knowledge about the breast cancer mortality reduction, false positive results and overdiagnosis associated with mammographic screening. The primary outcome was the mean number of marks assigned in each of the three themes and overall. There were three potential marks for questions about breast cancer mortality, one for false positives and six for overdiagnosis. RESULTS: Most women (91.7%) correctly reported that screened women are less likely to die of breast cancer than non-screened women. 39.7% of women reported having heard of a ‘false positive screening result’ and 86.2% identified the term’s definition; 51.3% of women had heard of ‘overdiagnosis’ and 14.8% identified the term’s definition. The mean score was 2.59 of 3 for questions about breast cancer mortality benefit and 0.93 of 1 for the question about false positive screening results. It was 2.23 of 6 for questions about overdiagnosis. CONCLUSIONS: Most participants correctly answered questions about the breast cancer mortality benefit and false positive results associated with screening. The proportion of correct responses to questions about overdiagnosis was modest, indicating that conceptual knowledge about overdiagnosis was lower. Qualitative studies that can obtain in-depth information about women’s understanding of overdiagnosis may help improve Norwegian-language information about this challenging topic.
format Online
Article
Text
id pubmed-8671979
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86719792021-12-28 Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study Tsuruda, Kaitlyn M Veierød, Marit B Houssami, Nehmat Waade, Gunvor G Mangerud, Gunhild Hofvind, Solveig BMJ Open Public Health OBJECTIVE: To investigate conceptual knowledge about mammographic screening among Norwegian women. DESIGN: We administered a cross-sectional, web-based survey. We used multiple-choice questions and a grading rubric published by a research group from Australia. SETTING: Our Norwegian-language survey was open from April to June 2020 and targeted women aged 45–74 years. PARTICIPANTS: 2033 women completed our questionnaire. We excluded 13 women outside the target age range and 128 women with incomplete data. Responses from 1892 women were included in the final study sample. PRIMARY AND SECONDARY OUTCOME MEASURES: The questionnaire focused on women’s knowledge about the breast cancer mortality reduction, false positive results and overdiagnosis associated with mammographic screening. The primary outcome was the mean number of marks assigned in each of the three themes and overall. There were three potential marks for questions about breast cancer mortality, one for false positives and six for overdiagnosis. RESULTS: Most women (91.7%) correctly reported that screened women are less likely to die of breast cancer than non-screened women. 39.7% of women reported having heard of a ‘false positive screening result’ and 86.2% identified the term’s definition; 51.3% of women had heard of ‘overdiagnosis’ and 14.8% identified the term’s definition. The mean score was 2.59 of 3 for questions about breast cancer mortality benefit and 0.93 of 1 for the question about false positive screening results. It was 2.23 of 6 for questions about overdiagnosis. CONCLUSIONS: Most participants correctly answered questions about the breast cancer mortality benefit and false positive results associated with screening. The proportion of correct responses to questions about overdiagnosis was modest, indicating that conceptual knowledge about overdiagnosis was lower. Qualitative studies that can obtain in-depth information about women’s understanding of overdiagnosis may help improve Norwegian-language information about this challenging topic. BMJ Publishing Group 2021-12-14 /pmc/articles/PMC8671979/ /pubmed/34907059 http://dx.doi.org/10.1136/bmjopen-2021-052121 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Public Health
Tsuruda, Kaitlyn M
Veierød, Marit B
Houssami, Nehmat
Waade, Gunvor G
Mangerud, Gunhild
Hofvind, Solveig
Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study
title Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study
title_full Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study
title_fullStr Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study
title_full_unstemmed Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study
title_short Women’s conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study
title_sort women’s conceptual knowledge about breast cancer screening and overdiagnosis in norway: a cross-sectional study
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671979/
https://www.ncbi.nlm.nih.gov/pubmed/34907059
http://dx.doi.org/10.1136/bmjopen-2021-052121
work_keys_str_mv AT tsurudakaitlynm womensconceptualknowledgeaboutbreastcancerscreeningandoverdiagnosisinnorwayacrosssectionalstudy
AT veierødmaritb womensconceptualknowledgeaboutbreastcancerscreeningandoverdiagnosisinnorwayacrosssectionalstudy
AT houssaminehmat womensconceptualknowledgeaboutbreastcancerscreeningandoverdiagnosisinnorwayacrosssectionalstudy
AT waadegunvorg womensconceptualknowledgeaboutbreastcancerscreeningandoverdiagnosisinnorwayacrosssectionalstudy
AT mangerudgunhild womensconceptualknowledgeaboutbreastcancerscreeningandoverdiagnosisinnorwayacrosssectionalstudy
AT hofvindsolveig womensconceptualknowledgeaboutbreastcancerscreeningandoverdiagnosisinnorwayacrosssectionalstudy